MedicaidPrior AuthMedium impact
2025.17 - Provider Bulletin - New Fasenra & Xolair Prior Authorization Clinical Criteria Requirements
Connecticut Medicaid (HUSKY Health)·CT · Pulmonology, Allergy & Immunology, Dermatology +3 more·Prior Authorization
Effective date
Jun 1, 2025
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid (HUSKY A, C, D) is implementing new prior authorization requirements for Fasenra (benralizumab) and Xolair (omalizumab) injections effective June 1, 2025. These medications for severe asthma, allergies, and other conditions will require specific clinical criteria documentation and PA approval before coverage.
Action Required
By June 1, 2025: Billing team must update systems to flag Fasenra (benralizumab) and Xolair (omalizumab) prescriptions for Connecticut HUSKY A, C, and D members as requiring prior authorization. Providers must complete specific PA forms available at ctdssmap.com and fax for approval before dispensing. Update encounter forms to remind providers of new PA requirements. Claims without prior authorization will be denied.